This site became the new on June 19th. Learn more.
Show more Menu IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu IMPORTANT: Talk with a trusted healthcare professional before volunteering for a study. Read more... Menu
Give us feedback

Efficacy of Vitamin C Injection on Fatigue in Workers After Work

This study has been completed.
Korean Association For Vitamin Research
Information provided by:
DongGuk University Identifier:
First received: March 3, 2008
Last updated: April 8, 2009
Last verified: April 2009
Fatigue is one of the most frequently observed symptoms for company workers, and oxidative stress is regarded as one of its cause. Vitamin C is a well-known antioxidant, and the investigators seek for evidence of the efficacy of high dose vitamin C parenteral supplement on fatigue symptoms of company workers after work.

Condition Intervention Phase
Fatigue Dietary Supplement: Ascorbic acid (Vitamin C) Dietary Supplement: Normal saline Phase 2 Phase 3

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Triple (Participant, Care Provider, Investigator)
Primary Purpose: Supportive Care
Official Title: Efficacy of High Dose Vitamin C Parenteral Supplement on Amelioration of Fatigue in Company Workers After Work: A Double-Blind, Randomized Controlled Trial

Resource links provided by NLM:

Further study details as provided by DongGuk University:

Primary Outcome Measures:
  • Degree of fatigue at the point of time with visual analogue scale from 0 to 10 [ Time Frame: Before intravenous vitamin C injection and right after completing injections, and one day later ]

Secondary Outcome Measures:
  • Reactive oxygen species [ Time Frame: Before intravenous vitamin C injections, right after completing injections, and one day later ]
  • Plasma vitamin C level [ Time Frame: Before intravenous vitamin C injections and right after completing injections ]

Enrollment: 150
Study Start Date: March 2008
Study Completion Date: May 2008
Primary Completion Date: May 2008 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
Intravenous injections of 10 grams(20ml as a solution) of vitamin C with 100ml of normal saline over 30 minutes.
Dietary Supplement: Ascorbic acid (Vitamin C)
Single intravenous injection of vitamin C 10g(20ml) with 100ml of normal saline over 30 minutes
Other Names:
  • Ascorbic acid
  • Merit C
Placebo Comparator: 2
Intravenous injections of 120ml of normal saline over 30 minutes.
Dietary Supplement: Normal saline
Single intravenous injection of 120ml of normal saline over 30 minutes

Detailed Description:
Previous studies dealing with vitamin C were focusing on terminal cancer patients or those with chronic fatigue syndrome. Since used drug dosage and the ways of administering vitamin C were not identical, the results were not consistent throughout those studies. This study is aimed to evaluate the efficacy of high dose vitamin C with parenteral supplement on relieving fatigue for apparently healthy volunteers.

Ages Eligible for Study:   20 Years to 49 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Company workers working at least 5 days a week from morning to evening
  • Volunteers who provided written informed consent

Exclusion Criteria:

  • Acute illness
  • Chronic disease such as diabetes, hypertension, liver disease, or renal disease
  • Previous history of renal stone or gout
  • Pregnant or lactating women
  • Hypersensitivity to vitamins or intravenous injections
  • History of vitamin supplements orally or parenterally within 2 days
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00633581

Korea, Republic of
DongGuk University International Hospital
Goyang-si, Gyeonggi-do, Korea, Republic of, 410-773
Sponsors and Collaborators
DongGuk University
Korean Association For Vitamin Research
Principal Investigator: Chang H Yeom, MD, PhD KwanDong University Myungji Hospital
  More Information


Publications automatically indexed to this study by Identifier (NCT Number):
Responsible Party: ChangHwan Yeom, Kwandong University College of Medicine Myungji Hospital Identifier: NCT00633581     History of Changes
Other Study ID Numbers: DUIH 2008-1-1
Study First Received: March 3, 2008
Last Updated: April 8, 2009

Keywords provided by DongGuk University:
ascorbic acid
oxidative stress

Additional relevant MeSH terms:
Signs and Symptoms
Ascorbic Acid
Growth Substances
Physiological Effects of Drugs
Molecular Mechanisms of Pharmacological Action
Protective Agents processed this record on August 18, 2017